Tornaphar SA
13.2 FTEThe score of Tornaphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +3 % Total assets 0 % Headcount (avg FTE) +89 %
Accounts of the company itself (not consolidated).
The full file covers 16 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Tornaphar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Oct 2026
- Year ended 31 Dec 2024filed on 13 Oct 2025
- Year ended 31 Dec 2023filed on 17 Oct 2024
- Year ended 31 Dec 2022filed on 12 Oct 2023
- Year ended 31 Dec 2021filed on 17 Oct 2022
Tornaphar's financial analysis
- Solvency24.8%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Tornaphar
Tornaphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0448.509.588
- VAT number
- BE0448509588
- Peppol
- Registered · 0208:0448509588 · as of 07 Nov 2026
- Legal form
- SA
- Incorporated
- 28 Sep 1992
- Registered office
- 7520 Tournai
- Size
- Small · 13.2 FTE
- Latest accounts
- 2025 · filed on 29 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Tornaphar (SA) has been based in Tournai since 1992, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 9,903 € and equity of 928,880 €; its revenue is not published. With 13.2 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 24.8%, below the median of its sector (41.5%).
Companies similar to Tornaphar
Companies in the same business, of comparable size and area, outside its group.
- Sirrah Retail sale of pharmaceutical products Tournai · balance sheet 84,897 €
- Apotheek Peeters - Petit Retail sale of pharmaceutical products Maasmechelen · balance sheet €5.05m
- Ludaphar Retail sale of pharmaceutical products Beauvechain · balance sheet €1.80m
- Pharmacie Deprez Retail sale of pharmaceutical products Charleroi · balance sheet €1.46m
- M.D.D. Pharma Retail sale of pharmaceutical products Wavre · balance sheet €12.2m
- Pharm-OZ Retail sale of pharmaceutical products Charleroi · balance sheet 681,585 €
- Blauwblomme Retail sale of pharmaceutical products Kortrijk · balance sheet 559,420 €
- Apotheken Solidaris Retail sale of pharmaceutical products Hasselt · balance sheet €8.84m
Frequently asked questions about Tornaphar
What is the revenue of Tornaphar?
Tornaphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Tornaphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0448509588 for Tornaphar, if the company is VAT-registered. Its company number (CBE) is 0448.509.588.
Where is the registered office of Tornaphar?
According to the CBE register, the registered office of Tornaphar is in 7520 Tournai.
What is the equity of Tornaphar?
At the close of the 2025 financial year, the equity of Tornaphar amounts to 928,880 €, a solvency of 24.8% of total assets.
How many people work at Tornaphar?
13.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Tornaphar?
The register lists 6 active mandates at Tornaphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Tornaphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →